Dr. Bernard Georges Jaar, MD

Dr. Jaar practices at Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System.

Dr. Jaar's NPI, 1962408617, was assigned on June 27, 2005. Dr. Jaar graduated from University of Haiti in 1987. Dr. Jaar holds Maryland license D0058306.

Dr. Jaar's primary practice is Johns Hopkins Bayview Medical Center, at 4940 Eastern Avenue, Baltimore, MD 21224 in Baltimore City. The practice phone is (410) 550-0123.

Dr. Jaar's primary practice is Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System. Dr. Jaar is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Jaar to 1 more dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jaar practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Jaar's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Jaar is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Jaar's licenses on file in 2 states: Maryland and Pennsylvania.

Dmand AI lists acute kidney failure, chronic kidney disease and fluid and electrolyte imbalances among the conditions Dr. Jaar treats.

CMS data shows 1,190 Medicare services from Dr. Jaar across 11 procedure codes in 2024, for 357 Medicare patients. Medicare paid $96,595 for them.

CMS counts 357 Medicare patients who saw Dr. Jaar in 2024. The largest group is 65 to 74, with 125 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 33% are also on Medicaid. Their average risk score is 5.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jaar's median patient age at 72, with 39% women.

In 2024, Dr. Jaar wrote 334 Medicare Part D claims for 60 patients. 89% of them were for generic drugs. CMS names the drug for 225 of them, across 11 drugs with 11 or more claims each, at $27,276 in total drug cost. In 2023, CMS named 157 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Jaar for performance year 2024, reported as part of a group. CMS lists Dr. Jaar as offering telehealth.

Dmand AI links 289 papers to Dr. Jaar, published from 2005 to 2025. 2017 was the busiest year, with 22. The most frequent topics are Renal Dialysis, Kidney Failure, Chronic and Renal Insufficiency, Chronic. Dr. Jaar has published most often in BMC Nephrol. Dr. Jaar's most frequent co-authors are Stephen Martin Sozio, MD, MHS, Tariq Shafi, MD and Michelle Mae Estrella, MD.

CMS Open Payments shows 1 general payment to Dr. Jaar from 1 drug or device company in 2024. Education make up the largest share, 100% of the total. Travere Therapeutics, Inc. paid the most, $3.

Dmand AI lists 5 awards for Dr. Jaar, most recently Institute for Excellence in Education’s Teaching Award for part-time faculty in 2018. Dr. Jaar serves on Education Committee - National Kidney Foundation and American Board of Internal Medicine - Nephrology Exam Writing Committee.

Dr. Jaar graduated from University of Haiti in 1987. Dr. Jaar is a member of ACP, ASN and ISN.

Dr. Jaar is in network with 11 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.